Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/17/01 → 12/31/05 |
Funding
- Celgene: $20,000.00
Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas and Medullary Thryroid Carcinomas
- Ain, Kenneth (PI)